Clover Biopharmaceuticals Ltd. engages in the research and development of biopharmaceutical products. It is a global clinical-stage biotechnology company which engages in developing novel vaccines and biologic therapeutic candidates. The firm's Trimer-Tag technology platform is a product development platform for the creation of novel vaccines and biologic therapies. The company was founded on October 31, 2018 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company